1. Home
  2. MLTX vs REAX Comparison

MLTX vs REAX Comparison

Compare MLTX & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • REAX
  • Stock Information
  • Founded
  • MLTX 2021
  • REAX 2018
  • Country
  • MLTX Switzerland
  • REAX United States
  • Employees
  • MLTX N/A
  • REAX N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • REAX
  • Sector
  • MLTX Health Care
  • REAX
  • Exchange
  • MLTX Nasdaq
  • REAX Nasdaq
  • Market Cap
  • MLTX 904.7M
  • REAX 820.5M
  • IPO Year
  • MLTX N/A
  • REAX N/A
  • Fundamental
  • Price
  • MLTX $12.95
  • REAX $3.60
  • Analyst Decision
  • MLTX Buy
  • REAX Strong Buy
  • Analyst Count
  • MLTX 9
  • REAX 3
  • Target Price
  • MLTX $36.78
  • REAX $6.33
  • AVG Volume (30 Days)
  • MLTX 2.3M
  • REAX 1.6M
  • Earning Date
  • MLTX 11-05-2025
  • REAX 10-30-2025
  • Dividend Yield
  • MLTX N/A
  • REAX N/A
  • EPS Growth
  • MLTX N/A
  • REAX N/A
  • EPS
  • MLTX N/A
  • REAX N/A
  • Revenue
  • MLTX N/A
  • REAX $1,813,907,000.00
  • Revenue This Year
  • MLTX N/A
  • REAX $55.78
  • Revenue Next Year
  • MLTX N/A
  • REAX $22.39
  • P/E Ratio
  • MLTX N/A
  • REAX N/A
  • Revenue Growth
  • MLTX N/A
  • REAX 65.60
  • 52 Week Low
  • MLTX $5.95
  • REAX $3.42
  • 52 Week High
  • MLTX $62.75
  • REAX $5.65
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 45.54
  • REAX 41.67
  • Support Level
  • MLTX $12.21
  • REAX $3.60
  • Resistance Level
  • MLTX $13.07
  • REAX $4.16
  • Average True Range (ATR)
  • MLTX 0.70
  • REAX 0.21
  • MACD
  • MLTX 1.36
  • REAX 0.03
  • Stochastic Oscillator
  • MLTX 94.63
  • REAX 27.89

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

Share on Social Networks: